Trial Profile
A Phase IIb, Open Label Study for the Detection of Dysplastic Colorectal Polyps during Colonoscopy after EMI-137 Injection in Patients with High Suspicion of Colorectal Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 02 Aug 2019
Price :
$35
*
At a glance
- Drugs EMI-137 (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Diagnostic use; Pharmacokinetics; Registrational
- Sponsors Edinburgh Molecular Imaging
- 02 Aug 2019 Status changed from recruiting to discontinued.
- 12 May 2019 This study has been discontinued in Netherlands.
- 20 Sep 2017 According to an Edinburgh Molecular Imaging media release, company has commenced this pivotal Phase IIb trial and interim results are expected in Q1 2018.